{"meta":{"query_hash":"1c0d6ab591e4","filters":{"venue":"Antiviral chemistry & chemotherapy"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1c0d6ab591e4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Antiviral+chemistry+%26+chemotherapy"},"results":[{"id":"W1983656219","doi":"10.1177/095632020601700601","title":"Five Years of Progress on Cyclin-Dependent Kinases and other Cellular Proteins as Potential Targets for Antiviral Drugs","year":2006,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cyclin-dependent kinase; Biology; Kinase; Drug discovery; Herpes simplex virus; Virology; Bioinformatics; Cancer; Virus; Cell biology; Cell cycle; Genetics","score_opus":0.011453017587526667,"score_gpt":0.30575447982002973,"score_spread":0.2943014622325031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983656219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.072409526,0.92267156,0.00008680206,0.00005410671,0.000078357036,0.0022437444,0.0006920978,0.000034899374,0.0017289111],"genre_scores_gemma":[0.07178875,0.91819704,0.0007620474,0.0001998746,0.0012363206,0.00053520326,0.002028797,0.00030375717,0.0049482253],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971623,0.00008107825,0.00058853626,0.0011206042,0.00043239805,0.0006151171],"domain_scores_gemma":[0.9986772,0.000029799432,0.00042373876,0.0006463461,0.00011115072,0.000111746296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022302277,0.000678004,0.0011291252,0.000061123865,0.00007894773,0.000059782975,0.0005284886,0.0008959359,0.000017665912],"category_scores_gemma":[0.00004488531,0.0006254702,0.0007731746,0.00013013762,0.00048049566,0.0000060497523,0.00015135284,0.0003685487,0.0000064578585],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032656884,0.00047247138,0.000006210216,0.006150835,0.00040410555,0.000026987833,0.00001815532,1.5861089e-7,0.44559515,0.000010051793,0.00090492814,0.54608434],"study_design_scores_gemma":[0.0008473629,0.00029610022,0.00000127569,0.00079907617,0.00011050055,0.000009100966,0.000010155089,0.0000025836675,0.6123689,0.000038794205,0.38504368,0.00047249667],"about_ca_topic_score_codex":0.000038239854,"about_ca_topic_score_gemma":9.0669243e-7,"teacher_disagreement_score":0.54561186,"about_ca_system_score_codex":0.000030590756,"about_ca_system_score_gemma":0.00021986954,"threshold_uncertainty_score":0.99961966},"labels":[],"label_agreement":null},{"id":"W1988861859","doi":"10.1177/095632020001100405","title":"Drug Resistance and Drug Combination Features of the Human Immunodeficiency Virus Inhibitor, BCH-10652 [(±)-2′-Deoxy-3′-Oxa-4′-Thiocytidine, dOTC]","year":2000,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Zidovudine; Zalcitabine; Virology; Lamivudine; Didanosine; Biology; Pharmacology; Chemistry; Virus; Viral disease","score_opus":0.00462799010712656,"score_gpt":0.23209112979432714,"score_spread":0.22746313968720058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988861859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96117073,0.0022181745,0.0000010508015,0.0035313736,0.000047045673,0.00036742503,0.000014712037,0.00007270672,0.032576803],"genre_scores_gemma":[0.8486062,0.00081609096,0.00016263603,0.00017727092,0.000063661355,0.000018318227,0.000050197315,0.000037110858,0.1500685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998307,0.00003848135,0.00041321781,0.00045038605,0.0004640859,0.00032685886],"domain_scores_gemma":[0.99910396,0.000045097648,0.00017844449,0.00051547325,0.000091652866,0.00006536015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001764314,0.00035084935,0.0004382875,0.00003786846,0.00028256024,0.000038490838,0.00021814246,0.00012124573,0.00029690046],"category_scores_gemma":[0.000015804007,0.0002580783,0.00017493131,0.00032754245,0.00031183494,0.00011773085,0.000037855287,0.00029546532,0.000011538206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032314024,0.0008905808,0.011967121,0.00033583984,0.00018810508,0.000020940222,0.0024241523,2.8458084e-7,0.95976585,0.00014392896,0.014351478,0.00958856],"study_design_scores_gemma":[0.00360774,0.00001818387,0.019150686,0.0004360354,0.00007034306,0.00001582761,0.00014525573,0.000003866718,0.96402663,0.00027922294,0.011973837,0.0002723929],"about_ca_topic_score_codex":0.000052753574,"about_ca_topic_score_gemma":0.000018272498,"teacher_disagreement_score":0.11749171,"about_ca_system_score_codex":0.00010724764,"about_ca_system_score_gemma":0.000095514035,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2001744429","doi":"10.1177/095632020401500402","title":"Mutations and Polymorphisms Associated with Antiretroviral Drugs in HIV-1C-Infected African Patients","year":2004,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fogarty International Center; National Institutes of Health","keywords":"Stavudine; Didanosine; Resistance mutation; Nevirapine; Efavirenz; Zidovudine; Lamivudine; Virology; Reverse transcriptase; Reverse-transcriptase inhibitor; Biology; Viral load; Regimen; Medicine; Internal medicine; Virus; Viral disease; Antiretroviral therapy; Polymerase chain reaction; Genetics; Gene","score_opus":0.0045901976957082825,"score_gpt":0.2143922775556601,"score_spread":0.2098020798599518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001744429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390155,0.000041209838,0.000013439867,0.0015071473,0.000013288513,0.00030429664,0.000023961153,0.00010076445,0.004094367],"genre_scores_gemma":[0.9952667,0.000036217676,0.00039060073,0.00016973812,0.00003238012,0.000023980621,0.00052544405,0.00004381821,0.0035111678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871,0.000014197722,0.0002532837,0.00037778745,0.0002818163,0.00036292875],"domain_scores_gemma":[0.99950564,0.000028715624,0.00011261715,0.00017546555,0.00007171685,0.00010584624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006295173,0.00028950794,0.00037227504,0.00007637123,0.00008185196,0.000028043074,0.00006168802,0.00012115546,0.000056601748],"category_scores_gemma":[0.00003026552,0.00024117836,0.000060908304,0.0004639428,0.00015468657,0.00011689454,0.000016812588,0.000186739,0.000013116674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026917222,0.0011846464,0.9720015,0.000031467727,0.00021680933,0.000052254247,0.002047866,0.0000011206913,0.021832919,0.00001045364,0.00011097103,0.0022408233],"study_design_scores_gemma":[0.024623018,0.00033728863,0.67713034,0.0004070816,0.00011181885,0.000015560212,0.0003426616,0.000031138185,0.29609838,0.00010495318,0.00025683845,0.00054091087],"about_ca_topic_score_codex":0.00004676449,"about_ca_topic_score_gemma":0.000009873602,"teacher_disagreement_score":0.29487115,"about_ca_system_score_codex":0.0002532946,"about_ca_system_score_gemma":0.00015174341,"threshold_uncertainty_score":0.98349684},"labels":[],"label_agreement":null},{"id":"W2014399345","doi":"10.1177/095632020701800201","title":"Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection","year":2007,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Reverse-transcriptase inhibitor; Pharmacology; Nucleoside Reverse Transcriptase Inhibitor; Emtricitabine; Nucleoside analogue; Nucleoside; Reverse transcriptase; Lamivudine; Deoxycytidine kinase; Didanosine; Resistance mutation; Zalcitabine; Biology; Virology; Deoxycytidine; Chemotherapy; Virus; Biochemistry; RNA","score_opus":0.04955322289353962,"score_gpt":0.3322231562892709,"score_spread":0.28266993339573127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014399345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041443217,0.9879849,0.0005534178,0.0009131012,0.00024333716,0.0042974534,0.0008066849,0.00016118842,0.0008955874],"genre_scores_gemma":[0.0014364371,0.98282164,0.0015649454,0.00011928337,0.00075185165,0.00040280446,0.0013714156,0.0002021236,0.011329508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680513,0.000027690448,0.0012862963,0.0008178394,0.00043524732,0.0006278209],"domain_scores_gemma":[0.99788094,0.0003198567,0.00064501987,0.00080521853,0.00017625085,0.00017271361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002902156,0.001062011,0.0024723217,0.0002079581,0.00019221501,0.000035011795,0.00020203221,0.00055155123,0.00013249557],"category_scores_gemma":[0.000038700226,0.0006793664,0.001882994,0.00078568823,0.00021581462,0.00007994841,0.000016242533,0.00028786293,0.000021809832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018234885,0.006209542,0.00026092335,0.023796115,0.006628526,0.000120322555,0.0007117476,4.922713e-7,0.03810285,0.000039998187,0.011992722,0.91031325],"study_design_scores_gemma":[0.0056171897,0.00036796732,0.000039980696,0.0040624742,0.0034536754,0.00006218082,0.000041517327,0.000014793856,0.05904878,0.0000035865883,0.92674565,0.0005421761],"about_ca_topic_score_codex":0.00006857642,"about_ca_topic_score_gemma":0.000013031715,"teacher_disagreement_score":0.91475296,"about_ca_system_score_codex":0.0007045132,"about_ca_system_score_gemma":0.00045791038,"threshold_uncertainty_score":0.9995658},"labels":[],"label_agreement":null},{"id":"W2021855902","doi":"10.1177/095632020501600502","title":"<i>In Vitro</i> Activity of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor (NRTI), against 215 HIV-1 Isolates Resistant to Other NRTIs","year":2005,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Didanosine; Abacavir; Zidovudine; Nucleoside Reverse Transcriptase Inhibitor; Lamivudine; Reverse transcriptase; Virology; Reverse-transcriptase inhibitor; Stavudine; Deoxycytidine; Zalcitabine; Deoxycytidine kinase; Resistance mutation; Biology; Human immunodeficiency virus (HIV); Virus; Viral load; Sida; Chemotherapy; Polymerase chain reaction; Viral disease; Biochemistry; Gemcitabine; Antiretroviral therapy","score_opus":0.008584953640573333,"score_gpt":0.24390346410491645,"score_spread":0.23531851046434313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021855902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730224,0.00027822214,0.00006552013,0.021509046,0.00004349582,0.0005294655,0.00008725835,0.00008591517,0.0043786597],"genre_scores_gemma":[0.9532642,0.00021421327,0.005318855,0.002792809,0.00040679643,0.00002517063,0.00004606514,0.0000938872,0.037838038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978549,0.00002900223,0.00057311653,0.0006287644,0.00035057683,0.0005636668],"domain_scores_gemma":[0.99892646,0.000041646796,0.00016459495,0.00051157706,0.0000626148,0.00029308282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018036034,0.00048315,0.00077404955,0.00013320454,0.00005559494,0.00002268862,0.00017495145,0.00020298194,0.00041964915],"category_scores_gemma":[0.00003301006,0.0004460261,0.00028386715,0.0005634489,0.00008704336,0.00022596776,0.000028868846,0.00027476458,0.00010389554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004124481,0.00088390446,0.0015307841,0.00014083584,0.00017232851,0.000075566786,0.0010044478,0.0000019046771,0.94885534,0.000001681879,0.031037133,0.012171576],"study_design_scores_gemma":[0.005503068,0.00007117017,0.00041621926,0.0002841289,0.000058301903,0.000010594402,0.00007228057,0.000049140304,0.8538786,0.000009128259,0.1392908,0.00035653997],"about_ca_topic_score_codex":0.00009020259,"about_ca_topic_score_gemma":0.000025074221,"teacher_disagreement_score":0.10825366,"about_ca_system_score_codex":0.00027898216,"about_ca_system_score_gemma":0.00026338152,"threshold_uncertainty_score":0.99979913},"labels":[],"label_agreement":null},{"id":"W2036804791","doi":"10.1177/095632020501600305","title":"Inhibition of Hepatitis B Virus Gene Expression and Replication by Helioxanthin and its Derivative","year":2005,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Hepatitis B virus; Nucleoside; Virology; Lamivudine; Biology; Nucleoside analogue; DNA; Virus; Molecular biology; Biochemistry","score_opus":0.011913783096706576,"score_gpt":0.2687079380968992,"score_spread":0.2567941550001926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036804791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951613,0.0025527875,0.000093887356,0.0010877551,0.000007856123,0.00022512207,0.0000551312,0.00004664065,0.0007695245],"genre_scores_gemma":[0.9819451,0.015811242,0.0011700473,0.000510655,0.000112852584,0.000024138391,0.00006468979,0.000025746222,0.00033555008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989874,0.000016627835,0.00027459627,0.00038133602,0.0001791881,0.00016089965],"domain_scores_gemma":[0.9993932,0.00003293594,0.00015478725,0.00022971934,0.00012762149,0.00006170147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010696151,0.00017711036,0.00030273106,0.000023595043,0.000075526856,0.000010425126,0.00003286665,0.00011805166,0.000057300833],"category_scores_gemma":[0.0000856736,0.00016784295,0.00003258136,0.00011967092,0.00010019721,0.00015435064,0.00003731306,0.00011445725,0.000003347817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008940208,0.000099656805,0.025493054,0.00013028017,0.000032834454,0.0000021538951,0.00056803314,4.8237496e-8,0.9632785,0.0000025040501,0.0014357287,0.008867848],"study_design_scores_gemma":[0.0011361447,0.000075278935,0.012025042,0.00017649969,0.000018702407,0.000016274204,0.000021172695,0.0000958399,0.9847672,0.00002642821,0.001494332,0.00014709088],"about_ca_topic_score_codex":0.00017267774,"about_ca_topic_score_gemma":0.000018184408,"teacher_disagreement_score":0.021488737,"about_ca_system_score_codex":0.00004030598,"about_ca_system_score_gemma":0.00002227211,"threshold_uncertainty_score":0.6844437},"labels":[],"label_agreement":null},{"id":"W2049579004","doi":"10.3851/imp1443","title":"Factors Affecting Template Usage in the Development of K65R Resistance in Subtype C Variants of HIV Type-1","year":2009,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; Reverse transcriptase; Template; DNA; Nucleotide; Molecular biology; Genetics; RNA; Mutation; Gene","score_opus":0.02272376542692057,"score_gpt":0.28006712304370757,"score_spread":0.257343357616787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049579004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492735,0.00056748453,0.0000050600165,0.000092236674,0.000016757,0.00013778576,0.000011951627,0.000007989103,0.0042334157],"genre_scores_gemma":[0.9990469,0.000058321293,0.00012215182,0.000019576028,0.0000055541,0.0000022862016,0.00006417164,0.0000067591454,0.0006742458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910384,0.000072946554,0.00029595374,0.00019124708,0.000059503065,0.00027649596],"domain_scores_gemma":[0.9995045,0.0001422363,0.000112780195,0.00020472196,0.00002674041,0.0000089898085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000316111,0.0001422642,0.00025909813,0.000040323637,0.0000435114,0.000004561638,0.00022127798,0.00012125256,0.00011015288],"category_scores_gemma":[0.000048972124,0.000099123856,0.000045188895,0.00026420443,0.000079767735,0.000041933537,0.000013065506,0.00019807361,0.000012542347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031504594,0.00034596064,0.062154878,0.000049468497,0.000051624254,0.0000105235285,0.0033188022,2.9417768e-7,0.93147445,0.000006265407,0.0001405134,0.002132153],"study_design_scores_gemma":[0.0009530752,0.000041902542,0.2972745,0.00007181548,0.0000023242767,0.0000013732778,0.00028788592,1.4176328e-7,0.70082295,0.000027029091,0.0004477508,0.000069241156],"about_ca_topic_score_codex":0.00001775185,"about_ca_topic_score_gemma":0.00006394631,"teacher_disagreement_score":0.23511961,"about_ca_system_score_codex":0.000040217055,"about_ca_system_score_gemma":0.00009444854,"threshold_uncertainty_score":0.40421537},"labels":[],"label_agreement":null},{"id":"W2077627087","doi":"10.1177/095632020401500504","title":"Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects","year":2004,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Foundation for AIDS Research; American Physicians Fellowship for Medicine in Israel; amfAR, The Foundation for AIDS Research","keywords":"Biology; Gene; Reverse transcriptase; Virology; Nucleotide; Protease; Lentivirus; Viral disease; Drug resistance; Virus; Sida; Genetics; Human immunodeficiency virus (HIV); Polymerase chain reaction; Enzyme","score_opus":0.017031320762275138,"score_gpt":0.28716780797670216,"score_spread":0.270136487214427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077627087","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057852034,0.94008654,0.00000563262,0.000057393747,0.000042966985,0.00070116075,0.0005855551,0.000032503925,0.0006362123],"genre_scores_gemma":[0.0563533,0.9406494,0.000022769984,0.00001953954,0.000033632023,0.000063485444,0.0025594598,0.000032634194,0.00026579064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793756,0.00048450628,0.00052755885,0.0005662404,0.00006903366,0.00041509364],"domain_scores_gemma":[0.9984527,0.0006294282,0.0002604339,0.000586249,0.00004805259,0.000023088634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004026665,0.0004563227,0.0012311249,0.000046319215,0.00006965731,0.000021074142,0.00039725777,0.00069259695,0.00038511062],"category_scores_gemma":[0.00009924913,0.0002975376,0.0002547453,0.00032148784,0.00035444775,0.000046184934,0.00006306434,0.0006485735,0.00008652474],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034665858,0.001421206,0.0036048605,0.007998744,0.0017987548,0.000077851975,0.0005514939,5.414652e-8,0.041405957,0.00000900675,0.00045245216,0.942333],"study_design_scores_gemma":[0.0052257692,0.0002580873,0.0011705585,0.006182302,0.00048687455,0.00015673516,0.000059222024,4.4950448e-7,0.069742635,0.00023085812,0.915672,0.0008145002],"about_ca_topic_score_codex":0.0002845365,"about_ca_topic_score_gemma":0.000011268467,"teacher_disagreement_score":0.9415185,"about_ca_system_score_codex":0.000102987,"about_ca_system_score_gemma":0.00034829226,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W2109240928","doi":"10.1177/2040206614566580","title":"Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor","year":2015,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Lignan; Reverse transcriptase; Reverse-transcriptase inhibitor; Nucleoside Reverse Transcriptase Inhibitor; Enzyme; Human immunodeficiency virus (HIV); Biology; Nucleoside; Mechanism of action; In vitro; EC50; Drug; Virology; Pharmacology; Chemistry; Biochemistry; Stereochemistry; Viral disease; Antiretroviral therapy; Sida; Viral load; RNA","score_opus":0.00906468489302717,"score_gpt":0.23144586016513236,"score_spread":0.22238117527210519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109240928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961377,0.00022622138,0.00030267186,0.00032449738,0.00008807171,0.0001967688,0.00015471129,0.000026107233,0.0025432636],"genre_scores_gemma":[0.99692696,0.00026286332,0.00022228951,0.00024108456,0.00031574134,0.00002041305,0.00019211571,0.000043689524,0.0017748548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983819,0.000042429518,0.00043509994,0.0005471469,0.0002602104,0.00033321316],"domain_scores_gemma":[0.9988774,0.000011206345,0.00027248918,0.000551522,0.00012975703,0.00015759848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031169478,0.00030548556,0.00033637,0.00003849205,0.00006027542,0.000032637992,0.0003123374,0.00027573458,0.00002594706],"category_scores_gemma":[0.000059336377,0.00029458763,0.00022497766,0.00017421908,0.00017599446,0.000021354112,0.00004322208,0.00012088238,0.000024662004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004283997,0.00031585767,0.0010485091,0.00006519509,0.00008942397,0.000008549747,0.000204329,0.0000017385645,0.99095666,0.0000026766033,0.004906285,0.0019723687],"study_design_scores_gemma":[0.0012640585,0.00014316675,0.00037698157,0.00005048084,0.00003423289,0.0000266306,0.00027473606,0.000042741933,0.9817103,0.000040599894,0.015695648,0.00034043196],"about_ca_topic_score_codex":0.000051049927,"about_ca_topic_score_gemma":0.0000035542967,"teacher_disagreement_score":0.010789363,"about_ca_system_score_codex":0.00002918068,"about_ca_system_score_gemma":0.00014823694,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W2313954337","doi":"10.1177/095632020401500401","title":"Potential of 4′-C-Substituted Nucleosides for the Treatment of HIV-1","year":2004,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ottawa Hospital Research Institute","keywords":"Human immunodeficiency virus (HIV); Stereochemistry; Chemistry; Pharmacology; Virology; Medicine","score_opus":0.023442323400439172,"score_gpt":0.310387022912384,"score_spread":0.28694469951194485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313954337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016607275,0.9952023,0.00009836148,0.00031140287,0.00008192599,0.001840037,0.00022712916,0.000042128057,0.00053601066],"genre_scores_gemma":[0.0017464277,0.9883187,0.0010989764,0.00001105115,0.00026038886,0.00019304827,0.0006759107,0.00008844494,0.0076070908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982346,0.0000136655,0.0007581054,0.0004217102,0.0002669616,0.00030490587],"domain_scores_gemma":[0.9985873,0.00012999083,0.0005358531,0.00057488325,0.00010893046,0.00006300906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007463942,0.00058920175,0.0020528208,0.000054520497,0.00007034819,0.000011348755,0.00020797666,0.00031071034,0.00014490043],"category_scores_gemma":[0.000011548273,0.00034403324,0.001395127,0.00022925224,0.00023437511,0.00003061628,0.000013502564,0.00010914491,0.000012607822],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033633356,0.0022846528,0.000060938353,0.028528653,0.0052756253,0.000038902643,0.00034287688,8.371325e-7,0.0037547962,0.000021375372,0.0007048412,0.9586502],"study_design_scores_gemma":[0.004330694,0.00017522789,0.000013461739,0.007046894,0.0035453842,0.000046688416,0.00003932571,0.0000051540715,0.105955705,0.00002151717,0.8785018,0.00031820583],"about_ca_topic_score_codex":0.000010395629,"about_ca_topic_score_gemma":5.3005186e-7,"teacher_disagreement_score":0.95833194,"about_ca_system_score_codex":0.00023988474,"about_ca_system_score_gemma":0.0006051309,"threshold_uncertainty_score":0.9999012},"labels":[],"label_agreement":null},{"id":"W2323588417","doi":"10.1177/095632020001100602","title":"Selection of Resistance-Conferring Mutations in HIV-1 by the Nucleoside Reverse Transcriptase Inhibitors (+/-)dOTC and (+/-)dOTFC","year":2000,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BioPhage Pharma (Canada); Jewish General Hospital","funders":"Medical Research Council Canada","keywords":"Reverse transcriptase; Resistance mutation; Biology; Mutation; Nucleoside; Virology; Nucleotidyltransferase; Virus; Genotype; Molecular biology; Genetics; RNA; Gene","score_opus":0.00566320649577984,"score_gpt":0.22530737920162283,"score_spread":0.219644172705843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323588417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845117,0.00028134105,0.000006429107,0.0043424554,0.0000120769955,0.00025317864,0.000021544514,0.00003671171,0.010534614],"genre_scores_gemma":[0.9616027,0.0004875019,0.0003630551,0.00021514362,0.000047088666,0.000022491935,0.00007392043,0.000025378027,0.037162714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990043,0.000020808911,0.0003106772,0.00027218007,0.0001772018,0.00021480306],"domain_scores_gemma":[0.9996625,0.000031307794,0.00006513846,0.0001563147,0.00003131715,0.000053400243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114114424,0.00019191808,0.00026450126,0.00003335175,0.000083470084,0.000015627693,0.00005854246,0.00008998822,0.00047176096],"category_scores_gemma":[0.000009201144,0.00015354042,0.00007780571,0.0002676373,0.00013582889,0.000096337295,0.0000043392283,0.00017299362,0.000009642879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006345795,0.00045213467,0.041894108,0.00021003866,0.00016819974,0.000026734493,0.0029813782,0.0000012331935,0.91263676,0.000009114616,0.026843008,0.014142697],"study_design_scores_gemma":[0.0033497352,0.000023678755,0.0049731936,0.00022062578,0.000061017752,0.000020549052,0.00045205324,0.000050392457,0.95283544,0.000048017624,0.037786003,0.00017927351],"about_ca_topic_score_codex":0.000039626568,"about_ca_topic_score_gemma":0.000019744128,"teacher_disagreement_score":0.040198687,"about_ca_system_score_codex":0.00006957245,"about_ca_system_score_gemma":0.00006191138,"threshold_uncertainty_score":0.6261197},"labels":[],"label_agreement":null},{"id":"W2326074019","doi":"10.1177/095632020401500302","title":"Clinical Utility of Current NNRTIs and Perspectives of New Agents in This Class under Development","year":2004,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Bristol-Myers Squibb; Boehringer Ingelheim","keywords":"Nucleoside Reverse Transcriptase Inhibitor; Reverse transcriptase; Dosing; Protease inhibitor (pharmacology); Virology; Reverse-transcriptase inhibitor; Pharmacology; Human immunodeficiency virus (HIV); ANTIRETROVIRAL AGENTS; Medicine; Biology; Antiretroviral therapy; Viral load; Genetics; RNA","score_opus":0.12437243587991338,"score_gpt":0.4137304869345004,"score_spread":0.289358051054587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326074019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026121128,0.97086644,0.000016231475,0.00015223051,0.000058977268,0.0007116177,0.0000144464375,0.000023905368,0.002035026],"genre_scores_gemma":[0.014193591,0.9801219,0.0009555179,0.000014323164,0.00008467088,0.000019382607,0.00011882745,0.00005022742,0.004441522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971625,0.000054188455,0.001388201,0.0007052781,0.0003797999,0.00031001907],"domain_scores_gemma":[0.998704,0.00008832267,0.0005743402,0.00040415843,0.00007774323,0.00015142163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003318973,0.0005532899,0.0024457402,0.000096074815,0.000025732612,0.000008180528,0.00017168545,0.00040458303,0.00044780772],"category_scores_gemma":[0.000041233092,0.00044247508,0.00048713063,0.00031583876,0.0002602431,0.00004489733,0.00007486134,0.0005040848,0.0000099065055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096567324,0.0013995303,0.008774019,0.017778244,0.00083985744,0.000016702783,0.0012481065,1.0611467e-8,0.000028670043,0.0000068243367,0.0007839156,0.9690276],"study_design_scores_gemma":[0.0063497806,0.00008217363,0.007276914,0.03880522,0.0007334417,0.000029011238,0.0002980382,0.0000021090339,0.009437346,0.00007762277,0.9361725,0.00073583843],"about_ca_topic_score_codex":0.000015013848,"about_ca_topic_score_gemma":0.000003124263,"teacher_disagreement_score":0.9682917,"about_ca_system_score_codex":0.0002723178,"about_ca_system_score_gemma":0.0020751585,"threshold_uncertainty_score":0.9998027},"labels":[],"label_agreement":null},{"id":"W2329003397","doi":"10.1177/095632020701800205","title":"Kinetics of Inhibition of HIV Type 1 Reverse Transcriptase-Bearing NRTI-associated Mutations by Apricitabine Triphosphate","year":2007,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Reverse transcriptase; Resistance mutation; Biology; Primer (cosmetics); Nucleotidyltransferase; Reverse-transcriptase inhibitor; Mutation; Molecular biology; Virology; Nucleoside Reverse Transcriptase Inhibitor; Wild type; Nucleoside; Mutant; Chemistry; RNA; Genetics; Gene","score_opus":0.009658679323601324,"score_gpt":0.24775137503491812,"score_spread":0.2380926957113168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329003397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947629,0.00032043,0.0002954567,0.00064667186,0.000031545456,0.00021019408,0.00005171107,0.000045276665,0.0036357904],"genre_scores_gemma":[0.99011135,0.00021119101,0.00085467537,0.00009938492,0.000028140914,0.0000031348636,0.00064316235,0.000030324854,0.00801866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987999,0.000009166695,0.00047333597,0.00020912374,0.00026710416,0.00024135542],"domain_scores_gemma":[0.99933875,0.00003635857,0.00021097183,0.00017002046,0.00017610277,0.000067771325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014834084,0.00018953977,0.00037389933,0.00004677801,0.000028152675,0.0000044917897,0.000051547737,0.00013249218,0.00019271331],"category_scores_gemma":[0.000040007984,0.0001819934,0.00012365323,0.00043529604,0.00009901169,0.00005600535,0.0000073488804,0.00011895418,0.0000064665696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033074603,0.00081842736,0.013391376,0.00013035063,0.00020184192,0.000016069216,0.0004648134,6.735954e-7,0.97937137,0.0000035684604,0.0038711631,0.0013995755],"study_design_scores_gemma":[0.004215291,0.00009446395,0.0039505814,0.00017604147,0.000118998236,0.000003942698,0.00016897995,0.000018273453,0.988768,0.000021143935,0.0023175324,0.00014674505],"about_ca_topic_score_codex":0.00001651575,"about_ca_topic_score_gemma":0.0000013138681,"teacher_disagreement_score":0.009440795,"about_ca_system_score_codex":0.00009001033,"about_ca_system_score_gemma":0.00003870852,"threshold_uncertainty_score":0.74214756},"labels":[],"label_agreement":null},{"id":"W2792985786","doi":"10.1177/2040206618762985","title":"Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa","year":2018,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"Bill and Melinda Gates Foundation","keywords":"Rilpivirine; Efavirenz; Virology; Reverse transcriptase; Reverse-transcriptase inhibitor; Nevirapine; Drug resistance; Nucleoside Reverse Transcriptase Inhibitor; Medicine; Resistance mutation; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Biology; Polymerase chain reaction; Genetics","score_opus":0.013935754908560982,"score_gpt":0.262476883679566,"score_spread":0.24854112877100504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792985786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827875,0.0005244559,0.00009023833,0.0029085083,0.000091229274,0.0005448681,0.000086323205,0.00017235064,0.0073032584],"genre_scores_gemma":[0.9612986,0.00017479277,0.0016638899,0.0004829533,0.0007282827,0.000061083985,0.00020351104,0.0000953081,0.0352916],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972514,0.000025069041,0.00057153916,0.00091435644,0.0004969566,0.00074069225],"domain_scores_gemma":[0.99867785,0.00005699161,0.00017517006,0.0007085579,0.00015022226,0.00023123452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016954869,0.000576036,0.0007075792,0.000104732055,0.00016251246,0.00009796006,0.00031808927,0.00024328667,0.0010779359],"category_scores_gemma":[0.00005001261,0.00049580756,0.00020787361,0.0005853139,0.00035102956,0.00017242516,0.000061135725,0.00029660936,0.00032013128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020894352,0.0006354918,0.85161006,0.00006166298,0.0002744092,0.00016273248,0.0053969766,0.0000012130326,0.13316476,0.000005762189,0.0045170397,0.0020804678],"study_design_scores_gemma":[0.0074742474,0.00022713136,0.16578346,0.00029865024,0.000029807561,0.000002402586,0.00013245735,0.00003958792,0.7689457,0.00011009535,0.05633606,0.00062043394],"about_ca_topic_score_codex":0.00010116218,"about_ca_topic_score_gemma":0.00014911305,"teacher_disagreement_score":0.6858266,"about_ca_system_score_codex":0.00021879563,"about_ca_system_score_gemma":0.00013007248,"threshold_uncertainty_score":0.9998352},"labels":[],"label_agreement":null},{"id":"W4210891386","doi":"10.1177/095632020701800601","title":"Montreal Welcomes 21st ICAR","year":2007,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacognosy; Biology; Biological activity; In vitro; Genetics","score_opus":0.06288153535063165,"score_gpt":0.4141452727979068,"score_spread":0.3512637374472751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210891386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391837,0.00009745521,0.0005097915,0.0057155667,0.000097986675,0.00022682917,0.000007875113,0.00015175584,0.054009005],"genre_scores_gemma":[0.9897269,0.00026294476,0.0018714543,0.004101725,0.000974149,0.0000043195755,0.00011122293,0.000046423735,0.0029008894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817336,0.000013134784,0.00069193874,0.00037041388,0.0003597728,0.00039140746],"domain_scores_gemma":[0.99879116,0.000313175,0.00020368866,0.00041132697,0.00013097518,0.00014968119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006574131,0.00021760764,0.00032952125,0.000029685218,0.00006387362,0.000023500386,0.00012185613,0.00016026183,0.0008087126],"category_scores_gemma":[0.00034063286,0.00020049553,0.000186213,0.00020862102,0.00010249887,0.00014540549,0.000028498494,0.00030785773,0.000086074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087171,0.00042785483,0.05618687,0.00008710837,0.00015854984,0.00008140953,0.00013206503,2.2444706e-7,0.71965224,0.000017715793,0.00866538,0.21371886],"study_design_scores_gemma":[0.0048416127,0.00013245651,0.09193069,0.00004594351,0.00009508165,0.00009253459,0.00058574456,0.000052231102,0.82417786,0.00017245604,0.07757429,0.0002991283],"about_ca_topic_score_codex":0.00021582031,"about_ca_topic_score_gemma":0.00002741002,"teacher_disagreement_score":0.21341974,"about_ca_system_score_codex":0.000083448605,"about_ca_system_score_gemma":0.00008420987,"threshold_uncertainty_score":0.8854836},"labels":[],"label_agreement":null},{"id":"W4318460047","doi":"10.1177/20402066231152971","title":"The development of BVDU: An odyssey","year":2023,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Varicella zoster virus; Nucleoside analogue; Famciclovir; Thymidine kinase; Herpes simplex virus; Deoxyuridine; Valaciclovir; Virology; Penciclovir; Biology; Virus; Herpesviridae; Nucleoside; Biochemistry; DNA; Viral disease","score_opus":0.07637125898134986,"score_gpt":0.39785224728950075,"score_spread":0.32148098830815086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318460047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054725977,0.98410916,0.000009886932,0.000034893565,0.00013176873,0.0007284333,0.00003171827,0.00018395015,0.009297571],"genre_scores_gemma":[0.0003750183,0.9910927,0.00033031646,0.000020202568,0.00023067398,0.000108713524,0.00022649221,0.000117975265,0.0074979146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982614,0.000030933756,0.0007159665,0.00039695573,0.0002684039,0.0003263595],"domain_scores_gemma":[0.998729,0.0001019865,0.00032479444,0.0006782509,0.00007135398,0.00009460307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025148652,0.00042709993,0.0011698527,0.00004021801,0.0002076516,0.000029582734,0.00022134093,0.00032054214,0.000092745366],"category_scores_gemma":[0.000024248819,0.00026212563,0.0004433361,0.0003778622,0.0001218802,0.00003822328,0.00003903107,0.00032160204,0.00013875337],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014667852,0.00022213113,0.00001728219,0.0053177057,0.000865452,0.000011482894,0.000069209425,7.183408e-9,0.00011986378,0.000003306394,0.00022508469,0.9931338],"study_design_scores_gemma":[0.00045231427,0.000036786954,0.000016143986,0.003740701,0.000317594,0.000022807706,0.000026157368,0.0000010878447,0.008738571,0.0000128269085,0.98641133,0.00022366134],"about_ca_topic_score_codex":0.0000103431075,"about_ca_topic_score_gemma":0.0000062341087,"teacher_disagreement_score":0.99291015,"about_ca_system_score_codex":0.00013815596,"about_ca_system_score_gemma":0.0006891142,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null}]}